Assertio Holdings (ASRT): O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Nevrologik mahsulotlar uchun ta'minot zanjirining optimallashtirilishi Assertio Holdings, Inc. (ASRT) kompaniyasi uchun yuqori marjalarni ta'minladi, ushbu kompaniya GURU.Markets platformasida P/E ning o'sish sur'ati tendentsiyasi orqali tahlil qilish uchun mavjud. 0.00 qiymati ushbu metrikaning joriy ko'rsatkichini ifodalaydi. Bunga hisob-kitoblarning raqamlashtirilishi va ishlab chiqarishni autsorsing qilish, shuningdek, aktivlarni qayta tuzilmagandan so'ng Heather Mason rahbarligida savdoning barqarorlashishi tufayli erishildi.
Assertio Holdings, Inc. (ASRT) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- kompaniyaning balans qiymati tafsilotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Jamlagan qarzning kapitalga nisbati Assertio Holdings, Inc.|ASRT - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti assertiotx.com|ASRT - Kompaniya qarzlari|Balans qiymatiga qarzlar Assertio Therapeutics|ASRT - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari Assertio|Oraliq qoplash koeffitsiyenti assertiotx.com
- foyda va multiplikatorlar bo'yicha ma'lumotlar:
ASRT - Kompaniyaning sof foydasi|Kutilayotgan sof foyda Assertio Holdings, Inc.|ASRT - Narxning foydaga nisbati|Kelajakdagi narxning foydaga nisbati assertiotx.com|ASRT - PEG multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Assertio Therapeutics|ASRT - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Assertio|ASRT - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun foydaning yillik o'sishi assertiotx.com|ASRT - Joriy yilda foyda o'sishi|Keyingi yil uchun bitta aksiya uchun sof foyda o'sishi prognozi Assertio Holdings, Inc.
Kompaniyaning fundamental tahlili:ASRT - Assertio Holdings
Assertio Holdings, Inc. (ASRT) nevrologik dori portfelini diversifikatsiya qilish orqali alohida patentlarga bo'lgan bog'liqligini kamaytirmoqda va foyda oqimlarini barqarorlashtirmoqda. Joriy PEG koeffitsiyenti kapitalizatsiyaning adolatli ekanligini aniqlash uchun P/E bozor bahosini ushbu o'sish sur'atlari bilan bog'laydi. Bir birlikdan past qiymat aktivning kengayishiga nisbatan qadrsizlanganligini anglatadi. Ushbu grafik operatsion muvaffaqiyatlar va aksiya narxi o'rtasidagi tafovutlarni ochib beradi. Investorlar qadrsizlangan "moonshot" loyihalarni aniqlash uchun ushbu filtrdan foydalanadilar.
Assertio Holdings, Inc. kimlar bilan raqobatlashadi
O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Biogen Inc|Narxning foydaga va o‘sish sur’atiga nisbati Neurocrine Biosciences Inc NBIX|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Regencell Corp (RGC)|Axsome Therapeutics - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda acadia-pharm.com|Xenon (XENE) - Narxning foydaga va o‘sish sur’atiga nisbati|Viking Therapeutics Inc - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori SUPN|CPRX (Catalyst Corp) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori DNLI|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati harmonybiosciences.com|Narxning foydaga va o‘sish sur’atiga nisbati Biohaven BHVN|Amylyx Pharmaceuticals Inc (AMLX) - O‘sish sur’atiga tuzatilgan narx-foyda|TRVI: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti PRAX (Praxis Corp)|AVXL: PEG multiplikatori|ceribell.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Prothena Corporation plc|O‘sish sur’atiga tuzatilgan narx-foyda Alector Therapeutics ALEC|Narxning foydaga va o‘sish sur’atiga nisbati Annexon Inc. (ANNX)|Narxning foydaga va o‘sish sur’atiga nisbati OMER (omeros.com)|PEG multiplikatori NGNE (Neurogene Inc.)|ACIU: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Voyager Therapeutics, Inc. - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Neumora NMRA|Scilex Holding Co. (SCLX) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti TVGN|ACOG (Alpha Cognition Inc) - PEG multiplikatori|CGTX - Narxning sof foyda o‘sishiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Inhibikase Therapeutics, Inc. (IKT)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Cassava Sciences Inc|Coya Therapeutics - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti VTGN|Ovid Rx - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati acumenpharm.com ABOS|CervoMed (CRVO) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti ATHE|CLNN (Clene Inc) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori PepGen Corp (PEPG)|Narx-foyda va o‘sish multiplikatori JUNS (Jupiter Neurosciences Inc)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati relmada.com|PEG multiplikatori ANVS (Annovis Bio)|PEG multiplikatori Grace Therapeutics Inc GRCE|AIFF - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Klotho Neurosciences Inc KLTO|neurosense-tx.com (NRSN) - Narxning foydaga va o‘sish sur’atiga nisbati|revivapharma.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori MTVA|NRXS (NeurAxis Inc.) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Helius Medical (HSDT)|passagebio.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori NEUP (Neuphoria Therapeutics)|minervaneurosciences.com (NERV) - O‘sish sur’atiga tuzatilgan narx-foyda|ATHA: Narx-foyda va o‘sish multiplikatori|ADXN - PEG multiplikatori|alzamend.com (ALZN) - Narxning foydaga va o‘sish sur’atiga nisbati|Cyclerion Therapeutics, Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Protagenic Therapeutics Inc.|O‘sish sur’atiga tuzatilgan narx-foyda Pasithea KTTA|PEG multiplikatori CRGT|PEG multiplikatori Avenue Therapeutics Inc. (ATXI)|Narxning foydaga va o‘sish sur’atiga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Cara Therapeutics Inc (CARA)|CHRO - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Eliem Therapeutics ELYM|ITCI: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Longboard Pharmaceuticals Inc (LBPH)|Narxning foydaga va o‘sish sur’atiga nisbati Marinus|NKGN: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori NRBO (NeuroBo Pharmaceuticals)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati SAGE|PEG multiplikatori SNPX (Synaptogenix)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Trevena Inc. (TRVN)|VIGL - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Anew Medical Inc.|CERE (Cerevel Therapeutics) - Narx-foyda va o‘sish multiplikatori
